baber/WOPTO huggingface dataset:
Patent CA-2601375-A1 (CA)
Inventor: SHAKES JONATHAN J
IPC: G06Q10/00
Filed: 2006-03-03
Abstract: Method and apparatus for multi-destination pick using motes. In embodiments, each receptacle may be assigned to a destination and may have a mote that may include an indicator that may be activated by a control system to indicate to the agent that the receptacle is the destination receptacle for a picked item.  The agent may then place the item in the indicated destination receptacle. A  mote may include a communication interface for communicating with a control system and with other motes in an ad-hoc network. In one embodiment, the mote on the destination receptacle may be activated when the picked item is scanned by the agent. In some embodiments, each receptacle may also have a sensor that detects when an item is placed in the receptacle to deactivate the indicator and/or to verify that the item was placed in the correct receptacle.
Patent CA-2601601-A1 (CA)
Title: Medical securing member placement system
Inventor: SANDERS ROY
IPC: A61B17/17
Filed: 2006-03-16
Abstract: An implant drill guide (12, 72) and tower (18, 78) with one or more indicators (20, 80) that may be aligned with the holes (8, 68) in the implant (6, 66) under fluoroscopy or other x-ray technique and may indicate the extents or boundaries of the securing member shaft or body. Certain embodiments involve methods of using a surgical system (2, 62) to predict or otherwise determine the placement and selection of a surgical securing member (10) . Certain embodiments involve the use of radiolucent indicators (20, 80) to allow more precise placement and selection of a surgical securing member (10) .
Patent CA-2601832-A1 (CA)
Title: Human detection and tracking for security applications
Inventor: ZHANG ZHONG
IPC: G06V10/46
Filed: 2006-05-31
Abstract: A computer-based system for performing scene content analysis for human detection and tracking may include a video input to receive a video signal; a content analysis module, coupled to the video input, to receive the video signal from the video input, and analyze scene content from the video signal and determine an event from one or more objects visible in the video signal; a data storage module to store the video signal, data related to the event, or data related to configuration and operation of the system; and a user interface module, coupled to the content analysis module, to allow a user to configure the content analysis module to provide an alert for the event, wherein, upon recognition of the event, the content analysis module produces the alert.
Patent CA-2606395-A1 (CA)
Inventor: PINDER HOWARD G
IPC: H04N7/167
Filed: 2006-04-27
Abstract: Processing an MPEG elementary stream contained in multiple PID streams in a conditional access overlay environment. A multi-program transport stream contains numerous video and audio elementary streams. Critical packets in the elementary streams are encrypted with two different encryption schemes creating a stream having multiple PID values. The streams are then sent from the headend to individual set-top boxes. One encryption scheme can be decoded by the incumbent set-top box and the second encryption scheme can be decoded by the overlay set-top box. The overlay set-top box uses a dual filter system to filter and decode the PIDs for each video and audio stream of the desired program.
Patent CA-2608019-A1 (CA)
Inventor: CLASS REINER
IPC: A61K38/17
Filed: 2006-05-04
Abstract: The invention relates to the use of at least one human recombinant histone, especially at least one histone H1 subtype, and/or a therapeutic histone fraction as a basis for the treatment of thrombocytopenia.
Patent CA-2609827-A1 (CA)
Title: Program execution apparatus and execution method
Inventor: HORII YUKI
IPC: H04N5/00
Filed: 2006-06-15
Abstract: A broadcast receiving apparatus which receives and reproduces broadcasts of plural broadcasting systems uses, in parallel, reproduction environments of the plural broadcasting systems, determines the broadcasting system to which a specified channel belongs at the time when a user selects the channel and switches the reproduction environment for reproducing the channel to the reproduction environment of the broadcasting system. Further, the broadcast receiving apparatus determines the reproduction environment of the broadcasting system to which the currently being reproduced channel belongs at the time when a key input is delivered from the user and switches a delivery destination of the key input to the reproduction environment of the broadcasting system.
Patent CA-2609923-A1 (CA)
Inventor: PALCIC PETER X
IPC: B64D35/00
Filed: 2006-04-28
Abstract: A transmission gearbox for a rotary-wing aircraft includes a main gearbox and a variable speed gearbox in meshing engagement with the main rotor gearbox.  The variable speed gearbox permits at least two different RPMs for the main rotor system without disengaging the engine(s) or changing engine RPMs. The variable speed gearbox includes a clutch, preferably a multi-plate clutch, and a freewheel unit for each engine. A gear path drives the main gearbox in a "high rotor speed mode" when the clutch is engaged to drive the main rotor system at high rotor rpm for hover flight profile. A reduced gear path drives the main gearbox in a "low rotor speed mode" when the clutch is disengaged and power is transferred through the freewheel unit, to drive the main rotor system at lower rotor rpm for high speed flight. The variable speed gearbox may be configured for a tail drive system that operates at a continuous speed, a tail drive system that changes speed with the main rotor shaft or for no tail drive system.
Patent CA-2610898-A1 (CA)
Title: Processes for the preparation of docetaxel
Inventor: HOLTON ROBERT A
IPC: C07D305/14
Filed: 2006-06-08
Abstract: The present invention provides processes for the production of docetaxel.  Docetaxel is produced by protecting the C(7) and the C(10) hydroxy groups of 10-DAB with a bridging silicon-based protecting group. The resulting 7,10 protected 10-DAB derivative is then derivatized and deprotected to form docetaxel.
Patent CA-2611626-A1 (CA)
Title: Multiple component moulded body comprising polyester layers
Inventor: HOEFLI KURT
IPC: B32B7/00
Filed: 2006-06-13
Abstract: The invention relates to a method for producing multiple component moulded bodies. Said method is characterised in that at least one layer of the moulded body is formed from a thermoplastic moulding compound consisting of A) between 10 and 99.99 wt. % of at least one thermoplastic polyester, B) between 0.01 and 50 wt. % of B1) at least one highly branched or hyperbranched polycarbonate having an OH index of between 1 and 600 mg KOH/g of polycarbonate (according to DIN 5324O1 part 2), or B2) at least one highly branched or hyperbranched polyester of type A*By where x is at least 1.1 and y is at least 2.1 or the mixtures thereof, and C) between 0 and 60 wt. % of other additives. The sum of the weight percentage of the constituents A) to C) is equal to 100 %.
Patent CA-2613991-A1 (CA)
Inventor: HOCHSTRASSER DENIS FRANCOIS
IPC: G01N33/68
Filed: 2006-07-14
Abstract: A brain damage-related disorder is diagnosed in a subject by detecting at least one polypeptide, or a variant or mutant thereof, in a sample of body fluid taken from the subject, wherein the polypeptide is one for which the level is either increased or decreased in cerebrospinal fluid from deceased patients compared to cerebrospinal fluid from healthy donors.
Patent CA-2615267-A1 (CA)
Title: Low power tissue ablation system
Inventor: WERNETH RANDELL L
IPC: A61B18/18
Filed: 2006-07-11
Abstract: Devices, systems and methods are disclosed for the ablation of tissue.  Embodiments include an ablation catheter that has an array of ablation elements attached to a deployable carrier assembly. The carrier assembly can be constrained within the lumen of a catheter, and deployed to take on an expanded condition. The carrier assembly includes multiple electrodes that are configured to ablate tissue at low power. Additional embodiments include a system that includes an interface unit for delivering one or more forms of energy to the ablation catheter.
Patent CA-2616937-A1 (CA)
Title: Indol-3-yl-carbonyl-piperidin and piperazin derivatives
Inventor: SCHNIDER PATRICK
IPC: A61K31/454
Filed: 2006-07-19
Abstract: The present invention relates to indol-3-yl-carbonyl-piperidin and piperazin derivatives which act as V1a receptor antagonists and which are represented by Formula (I) wherein the residues R1 to R3 are as defined herein. The invention further relates to pharmaceutical compositions containing such compounds, their use in medicaments against dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder, anxious and depressive disorders, and methods of preparation thereof.
Patent CA-2617150-A1 (CA)
Title: Use of chk2 kinase inhibitors for cancer treatment
Inventor: POMMIER YVES
IPC: A61K31/17
Filed: 2006-07-27
Abstract: Described herein are Chk2 -inhibitor compounds and derivatives thereof, and methods of treating or preventing disease and disease symptoms using the compounds and compositions thereof.
Patent CA-2619384-A1 (CA)
Inventor: HARJU BERT
IPC: F16H31/00
Filed: 2006-08-16
Abstract: The present invention encompasses a transmission arrangement (1 ) for translating a reciprocating translation movement, related to each of two gear rods (51 , 52), in mesh with its allotted gear wheel (10', 11 '), where a first gear rod and its associated first gear wheel (10') is representing a first prime motor arrangement (10), while a second gear rod and its associated second gear wheel (11 ') is representing a second prime motor arrangement (11 ), including its related freewheel bearing (7, 8). A gear wheel arrangement (4, 5, 6), including bevel gear wheels, is adapted to expose a first bevel gear wheel (4) in cooperation with said first gear wheel (10'), a second bevel gear wheel (6) in cooperation with said second gear wheel (11 ') and a third bevel gear wheel (5) adapted to mesh with said first and second gear wheels (4, 6), in order to adapt or to cause these first and second bevel gear wheels (4, 6) in different rotational directions. Said first bevel gear wheel (4) and its associated first gear wheel (10'), related to said first prime motor arrangement (10), are integrally formed as to form one first unit (100). Said second bevel gear wheel (6) and its associated second gear wheel (11 '), related to said second prime motor arrangement (11 ), are integrally formed as to form one second unit (200). Said first unit (100) and said second unit (200) are, via its related freewheel bearing (7, 8), pivotally supported by said shaft (2) at a first pivotal direction and fixedly or blockingly supported by said shaft (2) in an opposite second pivotal direction. Said first (100) and second (200) units are identically formed.
Patent CA-2620137-A1 (CA)
Inventor: KILPATRICK MICHAEL
IPC: C12Q1/68
Filed: 2006-09-22
Abstract: A method for detecting and quantitating multiple and unique fluorescent signals from a cell sample is provided. The method combines immunohistochemistry and a fluorescent-labeled in situ hybridization techniques. The method is useful for identifying specific subcellular components of cells such as chromosomes and proteins.
Patent CA-2623134-A1 (CA)
Title: Fabric care compositions and systems comprising organosilicone microemulsions and methods employing same
Inventor: PANANDIKER RAJAN KESHAV
IPC: C11D3/37
Filed: 2006-10-17
Abstract: Systems, compositions and methods for fabric laundering comprising selected organosilicones which are formulated into microemulsions for improved deposition onto fabrics to provide fabric care benefits.
Patent CA-2623769-A1 (CA)
Title: Composition et methode preventives contre les affections buccales
Inventor: DRAKE DAVID R
IPC: A61K33/00
Filed: 2008-02-29
Abstract: Linvention concerne lutilisation de dioxyde de chlore stabilisé dans une plage de concentration allant denviron 0,5 % à environ 0,9 % (p/v) sous forme dune composition pour la prévention dune maladie buccale grâce à des propriétés bactéricides et bactériostatiques au sein dun environnement microbien. Les propriétés bactéricides du dioxyde de chlore stabilisé sont en outre augmentées pour comprendre la destruction dun nombre accru de bactéries buccales à Gram négatif et à Gram positif anaérobies/aérobies/facultatives apparaissant dans des communautés microbiennes mélangées. On décrit également la découverte inhérente de propriétés bactériostatiques du dioxyde de chlore stabilisé présent au sein dun environnement microbien, qui inhibe le taux de régénération des bactéries buccales après exposition, ce qui a pour résultat une réduction significative de la production de plaque dentaire et des mauvaises odeurs buccales. Le dioxyde de chlore stabilisé peut être sous la forme dune solution de rinçage ou de bain de bouche.
Patent CA-2623824-A1 (CA)
Inventor: CRAZE DAVID
IPC: C10J3/02
Filed: 2006-08-18
Abstract: A method for power generation from carbonaceous feedstock comprising the steps of: gasifying the feedstock in a gasification unit to produce synthesis gas;  passing a first portion of the synthesis gas to a power generation unit;  passing a second portion of the synthesis gas to a chemical plant; condensing at least a portion of at least one gas stream produced; revaporising at least a portion of the at least one condensed gas stream; and wherein the step of revaporising at least a portion of the at least one condensed gas stream permits the power used in the step of condensing at least a portion of at least one gas stream to be recovered.
Patent CA-2624402-A1 (CA)
Title: Absorbent article
Inventor: NANBU CHINATSU
IPC: A61F13/49
Filed: 2006-09-27
Abstract: It is intended to provide an absorbent article which can prevent the leakage of excretory substances and lessens worsening in the feeling during attachment. An absorbent article (1) having a liquid-permeable front face sheet part (2), a liquid-impermeable back face sheet part (3), an absorbent part (4) located between the front face sheet part (2) and the back face sheet part (3), and an intermediate sheet part (5,6) located between the front face sheet part (2) and the absorbent part (4). The absorbent part (4) comprises a center absorbent part and a posterior absorbent part which is continuously formed in the posterior side of the center absorbent part in the longitudinal direction (LD) thereof. The intermediate sheet part (5,6) is composed of the first intermediate sheet (5) that is located between the front face sheet part (2) and the center absorbent part and the second intermediate sheet (6) that is located between the front face sheet part (2) and at least the posterior absorbent part and has liquid migration properties different from those of the first intermediate sheet (5).
Patent CA-2625426-A1 (CA)
Title: Dextran and arabinogalactan conjugates of therapeutically active compounds
Inventor: SOSKOLNI MARINA
IPC: A61K47/48
Filed: 2006-09-25
Abstract: The present invention discloses modified polymer conjugates of a polymer and a drug having reduced toxicity relative to the unmodified parent compound while retaining substantially the same degree of therapeutic activity as of the unmodified parent compound.
Patent CA-2628116-A1 (CA)
Title: Compositions and methods for diagnosing and treating cancer
Inventor: LEWICKI JOHN
IPC: C07K14/705
Filed: 2006-10-31
Abstract: The present invention relates to compositions and methods for characterizing, diagnosing, and treating cancer. In particular the invention provides the means and methods for the diagnosis, characterization, prognosis and treatment of cancer and specifically targeting cancer stem cells. The present invention provides a soluble FZD receptor comprising an extracellular domain of a human FZD receptor that inhibits growth of tumor cells. The present invention still further provides a soluble receptor comprising a Fri domain of a human FZD  receptor that binds a ligand of a human FZD receptor and said soluble receptor is capable of inhibiting tumor growth. The present invention still further provides a method of treating cancer comprising administering a soluble FZD  receptor comprising for example, either an extracellular domain of a human FZD  receptor or a Fri domain of a human FZD receptor, in an amount effective to inhibit tumor growth.
Patent CA-2628578-A1 (CA)
Inventor: GOYETTE PAUL
IPC: B65F1/16
Filed: 2008-04-07
Abstract: An accumulation/disposal bin includes a container body with an upper opening. A lid is mounted on a hinge on the forward wall of the body, to pivot about an axis proximate the upper opening. The lid pivots about the forward edge of the opening, allowing a lock to be formed on the rear edge of the lid. Edge mounted wheels may further be located proximate the rear bottom of the container, diagonally across from the hinge. The bin may further include a lifting slot on the rear wall. A handle may be formed proximate the upper opening on the rear of the bin. The lid may comprise a downwardly sloped ramp extending from an opening in a horizontal plane to beneath a portion of the lid that at least partially covers this horizontal plane. The ramp and the covering portion of the lid define first and second slots each in a generally vertical plane. The second slot provides an entrance to an interior of the container body.
Patent CA-2631829-A1 (CA)
Title: New method for bisulfite treatment
Inventor: MARKERT-HAHN CHRISTINE
IPC: C07H21/00
Filed: 2006-12-12
Abstract: The present application is directed to a method for performing a bisulfite reaction to determine methylation positions in a nucleic acid, i.e. methylated and non-methylated cytosines. In this method, the nucleic acid is bisulfite treated and is bound to a solid phase when an alkaline solution is added for desulfonation and elution of the nucleic acid from the solid phase. The nucleic acid can be amplified in an additional step. The solid phase is preferably a material comprising glass or silica, more preferably a glass fleece, glass membrane or a magnetic glass particle. Further, several uses of the alkaline solution for bisulfite treatment are disclosed and a kit containing a bisulfite reagent, a solid phase and an alkaline solution.
Patent CA-2633525-A1 (CA)
Inventor: FRANKEN EVA-MARIA
IPC: C07D307/94
Filed: 2006-12-11
Abstract: The invention relates to novel compounds of formula (I), wherein W, X, Y, Z, A, B, D, Q1, Q2, and G have the meanings indicated in the description, several methods and intermediate products for the production thereof, the use thereof as pesticides and/or herbicides and/or fungicides, as well as selectively herbicidal agents containing 3'-alkoxy-spirocyclopentyl-substituted tetramic and tetronic acids of formula (I) and at least one compound that improves plant tolerance. Also disclosed are a way to increase the effect of crop protection products containing agents from the class of 3'-alkoxy-spirocyclopentyl-substituted tetramic and tetronic acids of formula (I) by adding ammonium salts and/or phosphonium salts or adding ammonium salts or phosphonium salts and permeation enhancers, the corresponding agents, methods for the production thereof, and the use thereof in crop protection.
Patent CA-2633713-A1 (CA)
Inventor: LUTTERBUESE PETRA
IPC: C12N15/13
Filed: 2006-12-21
Abstract: The present invention relates to bispecific single chain antibodies comprising a first binding domain that irnmunospecifEcally binds to the T-cell antigen CD3 and a second binding domain that immunospecifically binds to the EphA2 receptor. Such bispecific single chain antibodies are encompassed by the term "EphA2-BiTEs."  The present invention further relates to methods and compositions designed for the treatment, prevention and/or management of disorders associated with aberrant expres-sion and/or activity of EphA2. Such disorders include, but are not limited to, cancer, non-cancer hyperproliferative cell disorders, and infections. The invention further relates to vectors comprising polynucleotides encoding the EphA2 -BiTEs of the invention, host cells transformed therewith, and their use in the production of said EphA2-BiTEs.  The invention also provides compositions, including pharmaceutical compositions, comprising any of the aforementioned EphA2-BiTEs, polynucleotides or vectors either alone or in combination with one or more prophylactic or therapeutic agents. Also disclosed are methods of screening for said EphA2-BiTEs and kits comprising any of the aforementioned compositions and diagnostic reagents.
Patent CA-2634150-A1 (CA)
Title: Improved operating strategies in filtration processes
Inventor: NGUYEN TINA
IPC: B01D61/22
Filed: 2007-01-12
Abstract: A method of operating a membrane filtration system having a number of repeated operation cycles, the method including the step of varying the values of one or more operating parameters of the system associated with a particular operation cycle between and/or during one or more repetitions of the operation cycle.  Membrane filtration systems operating in accordance with the method are also disclosed.
Patent CA-2635045-A1 (CA)
Title: Handheld electronic device and method for disambiguation of text input and providing spelling substitution
Inventor: RUBANOVICH DANIEL
IPC: H03M11/00
Filed: 2006-12-28
Abstract: A handheld electronic device includes a reduced QWERTY keyboard and is enabled with disambiguation software that is operable to disambiguate text input. The device is structured to identify and output representations of language objects that are stored in the memory and that correspond with a text input.  The device is additionally structured to identify and output representations of language objects that are stored in the memory and that correspond with a known spelling substitution particular to a language active on the handheld electronic device.
Patent CA-2635342-A1 (CA)
Title: Cytoprotective pharmaceutical combination which can be used in the prevention and treatment of systemic inflammatory response syndrome
Inventor: SELMAN-HOUSEIN SOSA MANUEL
IPC: A61P31/00
Filed: 2006-12-28
Abstract: The invention relates to a pharmacological combination of a protein with cytoprotective properties and an immunomodulatory peptide. The peptide of the pharmacological combination is the linear LALF31-52 peptide which increases immunological defence mechanisms without inducing an exacerbated inflammatory response. The protein of the pharmacological combination is the epidermal growth factor which has a cytoprotective effect and which activates the signal transduction of cell survival genes. The inventive pharmacological combination confers resistance on the systemic immunocompetent cells in order to withstand damage caused by inflammatory cytokines and by bacterial endotoxins without activating molecular apoptosis pathways. In addition, the pharmacological combination alleviates the inflammatory events of the first stage of sepsis and of the inflammatory response against sterile traumatisms, thereby defending the organism against the invasion of pathogens or against inflammation mediators, without the inflammatory response being deleterious to the integrity thereof.